drugset / Trial / NCT02761395
Study of The Therapeutic Benefits of Al-hijamah in Children With Beta Thalassemia Major
RandomizedParallel-groupSingle-blindTreatment
Summary
1. Evaluate the therapeutic effects, health benefits, and immunological effect of Al-hijamah in children with beta thalassemia major. 2. Evaluate the extent of clinical improvement, reductions in serum iron and ferritin, antioxidant status, in those patients.
Timeline
- Start
- 2015-11
- Primary completion
- 2017-05
- Completion
- 2017-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Deferasirox | Unknown | 20 mg/kg | Oral |
| Background | Deferasirox | Unknown | 40 mg/kg | Oral |